BUPIVACAINE AND EPI

The Defense Logistics Agency awarded delivery order SPE2DP26F7550 to DMS PHARMACEUTICAL GROUP INC under the base contract SPE2DX25D9900 for the procurement of 15.000 pounds of BUPIVACAINE AND EPI, identified by NSN 6505011277947, at a total price of $472.50. The award was issued on July 14, 2026, with a required delivery date of July 29, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor assumes all transportation costs and risks until delivery is completed. The product must be shipped using traceable freight methods, with parcel post explicitly prohibited, and delivery must be made precisely to the designated military logistics facility at BLDG A5474 PRATT ST, FORT BRAGG NC 28310. Inspection and acceptance are performed by the Government upon arrival at the destination, with no variance allowed in quantity. The contractor is required to submit invoices electronically through the Wide Area Workflow system in compliance with DFARS 252.232-7003, with payments processed by the Defense Finance and Accounting Service at P O BOX 182317, COLUMBUS OH 43218-2317. The contract uses the NAICS code 424210 for pharmaceutical wholesaling and is funded under accounting code BX: 97X4930 5CBX 001 2620 S33189. Contract administration is managed by Contracting Officer Lisa Quinn, with administrative support provided by Shairy M. Cartagena. No standard FAR or DFARS clauses, attachments, evaluation factors, or special requirements are specified within the delivery order itself, indicating these are governed by the underlying base contract. The awardee’s CAGE code is 1UNB0, and while socioeconomic status or representation certifications are not detailed, the order reflects minimal variation in scope, fixed pricing, and strict logistical compliance requirements typical of DLA pharmaceutical procurements.